Americas Safety Lancet Market by Product Type (Push Button Safety Lancet, Side Button Safety Lancet, and Pressure Activated Safety Lancet), By Application (Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testing, Allergy Testing, Neonatal Screening, and Others), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, and Home Care Setting) and Region (North America & South America) - Forecast to 2032

Americas Safety Lancet Market Overview

The Americas Safety Lancet was valued at USD 0.96 billion in 2023 and is projected to grow from USD 1.01 billion in 2024 to USD 1.82 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.89% during the forecast period (2024 – 2032). Increase in the prevalence of chronic disease such as diabetes and rise in prevention of needlestick injuries are the major factors driving the growth of market.

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Americas Safety Lancet Market Trends

Rising Prevalence of Diabetes

Ride in prevalence of diabetes is the major factor that drives the growth of market. Diabetes is a chronic condition that affects millions of people globally, and regular blood glucose monitoring is essential for managing the disease.

Safety lancets are commonly used for blood sampling in diabetic patients, as they provide a convenient and painless way to collect blood samples for glucose monitoring. Unlike traditional lancets, safety lancets have a built-in safety mechanism that reduces the risk of needlestick injuries and contamination, making them a safer option for patients and healthcare providers.

According to CDC report, in 2021, around 38.4 million people - 11.6% of US population - had diabetes, out of which, 29.7 million people of all ages had diagnosed diabetes and 8.7 million people (22.8% of adults are with diabetes) are undiagnosed. 1.7 million adults aged 20 years or older with diagnosed diabetes reported having type 1 diabetes and relying on insulin for treatment.

As the prevalence of diabetes continues to rise, the demand for safety lancets is also expected to increase. Additionally, technological advancements in safety lancet design and the introduction of innovative features such as retractable needles and automatic release mechanisms are further driving market growth.

Americas Safety Lancet Segment Insights

Americas Safety Lancet Product Type Insights

Based on Type, the market is segmented into Push Button Safety Lancet, Pressure Activated Safety Lancet, Side Button Safety Lancet. The push-button safety lancet held the largest share in the Americas safety lancet market because of its ease of use and convenience for healthcare professionals and patients. These safety lancets have a simple push-button mechanism that allows for quick and easy activation, reducing the risk of accidental needlestick injuries. Additionally, push-button safety lancets typically have adjustable depth settings, allowing for proper customization for each individual's skin type and blood draw requirements. Overall, the push-button safety lancet is a popular choice in the market due to its user-friendly design and safety features.

FIGURE 2: AMERICAS SAFETY LANCET SIZE, BY PRODUCT TYPE, 2023 & 2032 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Americas Safety Lancet Application Insights

Based on the Application, The Americas Safety Lancet includes Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testing, Allergy Testing, Neonatal Screening, and Others.

Among these, Glucose testing held the largest share in the Americas safety lancet market because it is a common and essential procedure for diabetics to monitor their blood sugar levels regularly. Safety lancets are used to draw blood quickly and safely for glucose testing, making them a necessary tool for diabetics. With the increasing prevalence of diabetes worldwide, the demand for safety lancets for glucose testing is expected to continue to grow, leading to their dominant share in the market. Additionally, the convenience and ease of use provided by safety lancets have also contributed to their widespread adoption among healthcare professionals and patients.

Americas Safety Lancet End-User Insights

The market segments of Americas Safety Lancet based on End-Users includes Hospitals & Clinics, Ambulatory Surgery Centers, and Home Care Setting. The Hospitals & Clinics segment held the majority of the market and is the fastest-growing segment during the forecast year due to the growing demand for frequent glucose testing, hemoglobin testing, cholesterol testing, allergy testing, coagulation testing, and neonatal screening across the region is driving the growth of market.

Americas Safety Lancet Regional Insights

By Region, the market is bifurcated into North America and South America. North America held the largest share in the Americas safety lancet market due to a well-established healthcare infrastructure with high healthcare expenditure, leading to greater adoption of safety lancets in the region. Additionally, the presence of key market players and advancements in healthcare technology are also contributing factors. Moreover, strict regulations and initiatives promoting safe healthcare practices in the region have further fueled the demand for safety lancets. Overall, these factors have collectively contributed to North America holding the largest share in the safety lancet market.

South America is experiencing the fastest growth in the safety lancet market due to several factors. One of the key reasons for this growth is the increasing awareness and importance of blood glucose monitoring in the region. With the rising prevalence of diabetes and other chronic conditions in South America, there is a growing demand for safe and convenient ways to collect blood samples for testing. Safety lancets provide an easy and painless solution for individuals to monitor their blood glucose levels regularly.

Additionally, the growing healthcare infrastructure in South America and the increasing adoption of advanced medical technologies have also contributed to the rapid growth of the safety lancet market in the region. Healthcare providers are increasingly using safety lancets in hospitals, clinics, and other healthcare facilities to ensure the safety of patients and healthcare workers during blood sample collection.

Overall, the combination of increasing awareness about the importance of blood glucose monitoring, improving healthcare infrastructure, and the availability of advanced safety lancet products has made South America the fastest growing market for safety lancets. As the demand for these devices continues to rise, the safety lancet market in the region is expected to further expand in the coming years.

FIGURE 3: AMERICAS SAFETY LANCET SIZE, BY REGION, 2023 & 2032 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Americas Safety Lancet Key Market Players & Competitive Insights

The Americas Safety Lancet is marked by the presence of numerous global, regional, and local vendors catering to the demands of a large patient population affected by conditions like diabetes and infectious diseases. This market is highly competitive, with companies both competing and cooperating to capture a significant share. Key drivers of growth include expanding into new, unexplored markets, launching innovative products, forging strategic partnerships, and implementing measures to enhance operational efficiency. Market players employ diverse strategies and advanced research and development techniques to expand their market presence and ensure sustainability.

Mergers and collaborations were also observed to expand the company's product portfolio, as well as introduce new safety lancets. The growth of prominent industry players is dependent on various factors, such as market conditions, FDA approvals, and industry development. It is also projected that a rise in the investments for R&D will also boost the market's growth in the upcoming future.

Major players in the Americas Safety Lancet Market, including Becton, Dickinson and Company, Inc, Dynarex Corporation, Abbott Laboratories, ICU Medical, Inc., Cardinal Health, LifeScan IP Holdings, LLC, and others, are making investments in R&D activities to boost market demand.

In recent years, major players have increasingly engaged in strategic collaborations for product development and geographical expansion into untapped markets to achieve operational excellence and strengthen their market positions in the Americas safety lancet market.

Americas Safety Lancet Industry Developments

September 2022: Tasso has obtained 510(k) clearance for its blood lancet, allowing the company to introduce a device aimed at fulfilling the growing need for remote testing services. Known as Tasso+, this product is engineered to facilitate blood collection in home settings. Users simply adhere the device to their arm and activate it by pressing a button, which deploys a lancet and starts the blood collection process.

In January 2024, the Commission on Primary Health Care (PHC) and Resilience in Latin America and the Caribbean (LAC) was established in January 2024 by the Lancet Americas, the World Bank, and the Pan American Health Organization (PAHO). Its primary objectives are as follows: establish a comprehensive conceptual policy framework for PHC and resilience; identify and define the key investments that LAC countries could undertake; and conduct a thorough assessment of the foreseen consequences. As commissioners, a multidisciplinary group comprising experts, managers, policymakers, and civil society leaders will strive to guarantee substantial technical knowledge, gender parity, and LAC representation.

In November 2023, the Medtronic Symplicity Spyral™ renal denervation system was granted approval by the U.S. Food and Drug Administration (FDA) for distribution within the United States. The system, which has been granted the Breakthrough Device designation by the FDA, disrupts hyperactive neurons in the kidneys via radio frequency in order to assist in the reduction of blood pressure. There are now, for the first time, medical device-related procedures that have received approval for the treatment of hypertension in the United States.  Particularly for those patients whose hypertension does not respond to medication or who have difficulty adhering to their medication regimen, Symplicity Spyral possesses the capacity to significantly impact their lifestyles. When combined with pharmacological interventions and modifications to one's lifestyle, renal denervation presents a viable and secure alternative for the long-term management of hypertension.

The lancet market is significantly driven by the increasing incidence of infectious and chronic diseases, enhanced medical device regulations, growing preference for home healthcare, and the rising prevalence of diabetes. 

Key Players in Americas Safety Lancet Market

Key Companies in the Americas Safety Lancet include

• Becton, Dickinson and Company


• Dynarex Corporation


• Abbott Laboratories


• LifeScan IP Holdings, LLC


• ICU Medical, Inc.


• Cardinal Health


• Simple Diagnostics


• Medline Industries, LP.


• McKesson Medical-Surgical Inc.


• Trividia Health, Inc.


• Tasso, Inc.

Americas Safety Lancet Market Segmentation

By Type

• Standard


• Safety Blood Lancets


• Vacuum Blood Lancets

By End-User

• Hospitals &Clinics


• Blood Banks


• Homecare


• Others

Factors driving this growth include:

• Rising chronic diseases like diabetes requiring frequent blood testing.


• Increased focus on home healthcare and self-monitoring.


• Growing government initiatives for diabetes checkups.


• New product launches with features like pain reduction or variable depth settings.


• Strategic partnerships to expand their reach or distribution channels.


• Investments in R&D for technologically advanced lancets.

In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Safety Lancet. We are thankful for the support and assistance from Safety Lancet. industry chain related technical experts and marketing experts during Research Team survey and interviews.